Purpose-built for physicians Combination bimagrumab plus semaglutide confers weight loss while preserving lean mass Key takeaways: Adding bimagrumab 30 mg/kg to semaglutide 2.4 mg conferred weight loss of more than 20% at 72 weeks in patients with obesity
GIP activation works synergistically with GLP-1, further enhancing insulin secretion and improving the body's response to glucose
You can also administer a loading dose this is a 1ml injection every second day for 3 injections total and then the normal dose of 1ml every 4 to 6 weeks
Across those sources, a consistent range has emerged for subcutaneous or under-the-skin injections
Precautions Patients with a history of thyroid cancer or pancreatitis should discuss potential risks with their healthcare provider before starting semaglutide injection
Most often, the vein selected for the procedure will be in the patients arm (just below the elbow), the back of the patients hand, or in some circumstances, in the patients foot